JSM 2015 Preliminary Program

Online Program Home
My Program

Abstract Details

Activity Number: 372
Type: Contributed
Date/Time: Tuesday, August 11, 2015 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #316490
Title: Correlations of Patient-Reported Outcomes with PSA and Survival Endpoints in Prostate Cancer Patients
Author(s): Xuemei Li*
Companies: Janssen R&D
Keywords: Correlation ; Patientreported outcome, ; Prostate cancer
Abstract:

Prostate cancer patients often experience mild to severe pain, it is therefore of interest to demonstrate if a new cancer therapy delays pain progression and improve the patient report outcomes (PRO). In many prostate cancer clinical trials, pain and PRO endpoints are included as secondary efficacy endpoints, in addition to PFS and overall survival endpoints. A meta-analysis is performed by pooling several randomized, placebo-controlled prostate cancer trials, correlations of PRO results with PSA response, time to PSA progression, PFS, and overall survival are explored. Suggestions are also made for PRO data collection.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2015 program





For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home